BeiGene, Ltd. Investors: Please contact the Portnoy Law Firm to recover your losses
Investors can contact the law firm at no cost to learn more about recovering their losses
LOS ANGELES, June 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises BeiGene, Ltd. (“BeiGene” or “the Company”) (NASDAQ: BGNE) investors that the law firm has initiated an investigation on behalf of investors that lost money on their BeiGene stock. BeiGene investors are encouraged to contact the firm to discuss their legal rights.
Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case via www.portnoylaw.com. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors’ options for pursuing claims to recover their losses.
An investigation is underway to determine whether the Company provided inaccurate or deceptive statements or failed to disclose important information that could affect investors. BeiGene has become the subject of an article published by Morningstar on June 15, 2023, titled "BeiGene experiences share price decline following patent infringement lawsuit by AbbVie unit over cancer drug." As reported in the article, AbbVie's (ABBV) Pharmacyclics unit has filed a lawsuit alleging patent infringement against BeiGene, specifically regarding their production and sale of Brukinsa, a treatment for chronic lymphocytic leukemia and small lymphocytic lymphoma. The complaint, filed in federal court in Delaware on Tuesday, asserts that BeiGene's Brukinsa infringes on Pharmacyclics' patent for Imbruvica, which is also used to treat the same conditions. In January, Brukinsa received approval from the U.S. Food and Drug Administration for the treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. As a result of this news, BeiGene's shares declined by 3.4% on the same day.
Please visit our website to review more information and submit your transaction information.
The Portnoy Law Firm represents investors in pursuing claims against caused by corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.
Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com
Attorney Advertising